Where Laser Fits in Your Wound Care
Practice: Clinical Use, Metrics, and Investment Justification
If you are evaluating whether to add laser to your wound program, the most realistic way to think about it is as an adjunct to the care you already know matters: vascular assessment, debridement, offloading, compression, infection control, moisture balance, advanced dressings, and referral escalation when needed.
Laser makes the most sense when you want another tool for chronic, slow-to-progress wounds that are already being managed appropriately but are not moving as quickly as expected. The strongest published support is in diabetic foot ulcer care, where reviews have reported better healing trajectory, wound size reduction, and faster progression when photobiomodulation is added to standard care.
OVERVIEW
-
IN YOUR CURRENT ALGORITHM
In practical terms, laser belongs after you have identified the main barriers to healing and started the standard interventions that address them. It should support your existing wound pathway, not compete with it.
That usually means laser is most appropriate once perfusion has been assessed, pressure or shear is being addressed, infection has been evaluated, and the wound is being followed with serial measurements. If those fundamentals are not in place, adding laser will not solve the underlying reason the wound is stalled.
BEST FIRST CASES
If you are considering a first purchase, the most practical use cases to evaluate include:
Venous leg ulcers, usually on the lower leg and often linked to swelling and poor venous return.
Pressure injuries, including bed sores over bony areas, especially in patients with limited mobility.
Diabetic foot ulcers, commonly in patients with diabetes and often located on the foot or lower leg.
Traumatic wounds that do not heal normally, including lacerations and contusions.
Post-surgical wounds, including incisions that reopen, become infected, or heal slowly.
These are reasonable categories to pilot because they are common in wound practice, can be followed with serial measurement, and give you a clearer opportunity to see whether laser is improving wound trajectory in a way you can actually document.
CLINICAL OUTCOMES TO TRACK:
-
WHY IT MATTERS:
You need to compare like with like before deciding whether the modality is helping.
-
WHY IT MATTERS TO YOU:
Area reduction is one of the most practical early signs that treatment is working.
-
This shows whether the wound trajectory is changing before closure occurs.
-
This gives you an earlier checkpoint than waiting only for full closure.
-
WHY IT MATTERS:
These are the clearest endpoints for judging clinical value.
-
This shows whether the wound trajectory is changing before closure occurs.
-
These reflect whether better wound progression is translating into fewer serious complications.
-
WHY IT MATTERS:
This affects adherence, patient experience, and tolerance for repeat treatment.
OPERATIONAL OUTCOMES TO TRACK:
-
WHY IT MATTERS:
Fewer visits per healed wound is one of the clearest economic benefits.
-
WHY IT MATTERS TO YOU:
This tells you whether laser improves workflow or slows it down.
-
WHY IT MATTERS:
Extra charting can erase efficiency gains if it is not planned for.
-
WHY IT MATTERS:
This shows whether the device improves throughput. -
WHY IT MATTERS:
A laser is only as good as the consistency of how it is used.
-
WHY IT MATTERS:
This helps you see whether laser changes downstream resource use.
HOW TO JUSTIFY THE INVESTMENT:
-
If you are making the buying decision, the strongest justification is not novelty. It is whether the device helps you close wounds faster, reduce repeat visits, and use clinician time more effectively.
-
Chronic wounds become expensive because they stay open and keep returning to the schedule. If laser shortens the number of visits needed to get a wound to closure, that creates value immediately.
Your best baseline is your own historical wound data, using similar wound types and similar levels of severity.
-
The evidence is strongest in diabetic foot ulcers, where adjunctive photobiomodulation has been associated with better healing progress and improved closure outcomes compared with standard care alone. For you, that matters because every wound that closes sooner reduces the chance of prolonged treatment, escalation, and high-cost complications.
A practical buying question is not whether laser solves every wound. It is whether, in the right patients, it improves the healing curve enough to justify the capital and training.
STAFF EFFICIENCY
The labor side matters more than many buyers expect. If the device helps shorten wound episodes, standardize treatment, and reduce the number of prolonged low-progress cases on the schedule, it may create real staff capacity.
This should be measured during your pilot, because any added modality can also increase setup time and documentation burden if the workflow is not designed carefully.
PILOT RECOMMENDATION
-
If you are close to a purchase decision, the most defensible next step is to purchase one unit and pilot it with a narrow case mix and strict measurement discipline. Start with diabetic foot ulcers and selected chronic lower-extremity wounds where you already have repeat follow-up and reliable documentation.
Use a single protocol for each wound category, require baseline photography and serial measurements, and compare results against similar historical cases from your own practice. That will tell you far more than a generic vendor claim.
EXECUTIVE ANSWER
-
Laser fits most realistically as an adjunctive tool in your wound algorithm after the fundamentals are in place and when you want to improve healing trajectory in chronic wounds that are not progressing as expected. From day one, you should track wound progression, closure, complications, visit count, clinician time, and protocol adherence.
The investment is easiest to justify when you can show fewer visits, faster healing, and better use of staff time in your own patient population.
REFERENCE LIST
-
Sutton E. Photobiomodulation and diabetic foot and lower leg ulcer management review. https://www.sciencedirect.com/science/article/abs/pii/S0958259221000730
Mendes-Costa LDS, et al. Systematic review and meta-analysis of the most used photobiomodulation parameters in diabetic foot ulcers. https://pubmed.ncbi.nlm.nih.gov/33190161/
Efficacy of low-level light therapy for treatment of diabetic foot ulcer: A systematic review and meta-analysis of randomized controlled trials. https://www.sciencedirect.com/science/article/abs/pii/S0168822718305680
Clinical Effect of Photobiomodulation on Wound Healing of Diabetic Foot Ulcers. https://pubmed.ncbi.nlm.nih.gov/36573132/
Effectiveness of Photobiomodulation Therapy on diabetic peripheral neuropathy outcomes. https://pubmed.ncbi.nlm.nih.gov/37622461/
Burden of diabetic foot ulcers for Medicare and private insurers. https://pubmed.ncbi.nlm.nih.gov/22049568/
The cost of diabetic foot ulcers and amputations to the National Health Service in England. https://onlinelibrary.wiley.com/doi/10.1111/dme.13973
CMS. Skin Substitute Grafts/Cellular and/or Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=59518&ver=4
AHRQ. How do we measure our pressure ulcer rates and practices? https://www.ahrq.gov/patient-safety/settings/hospital/resource/pressureulcer/tool/put5.html
A Prospective Study of Pressure Injury Healing Rate and Healing Time. https://journals.lww.com/aswcjournal/fulltext/2022/12000/a_prospective_study_of_pressure_injury_healing.10.aspx
Review of light parameters and photobiomodulation efficacy. https://pmc.ncbi.nlm.nih.gov/articles/PMC8355782/